Skip to main content
NCBI home page
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2022 May 15;61(21):8105–8111. doi: 10.1021/acs.inorgchem.2c00602

Toward Environmentally Benign Electrophilic Chlorinations: From Chloroperoxidase to Bioinspired Isoporphyrins

Silène Engbers †, Ronald Hage †,‡, Johannes E M N Klein †,*
PMCID: PMC9157495  PMID: 35574587

Abstract

graphic file with name ic2c00602_0009.jpg

Recent desires to develop environmentally benign procedures for electrophilic chlorinations have encouraged researchers to take inspiration from nature. In particular, the enzyme chloroperoxidase (CPO), which is capable of electrophilic chlorinations through the umpolung of chloride by oxidation with hydrogen peroxide (H2O2), has received lots of attention. CPO itself is unsuitable for industrial use because of its tendency to decompose in the presence of excess H2O2. Biomimetic complexes (CPO active-site mimics) were then developed and have been shown to successfully catalyze electrophilic chlorinations but are too synthetically demanding to be economically viable. Reported efforts at generating the putative active chlorinating agent of CPO (an iron hypochlorite species) via the umpolung of chloride and using simple meso-substituted iron porphyrins were unsuccessful. Instead, a meso-chloroisoporphyrin intermediate was formed, which was shown to be equally capable of performing electrophilic chlorinations. The current developments toward a potential method involving this novel intermediate for environmentally benign electrophilic chlorinations are discussed. Although this novel pathway no longer follows the mechanism of CPO, it was developed from efforts to replicate its function, showing the power that drawing inspiration from nature can have.

Short abstract

Chloroperoxidase, first isolated in the 1960s, was found to catalyze electrophilic chlorinations via the umpolung of chloride. Fascinated by this curious transformation, efforts were made to perform such a reactivity in the absence of the enzyme, which is susceptible to hydrogen peroxide-dependent decomposition. This viewpoint describes how the field evolved into the discovery of meso-chloroisoporphyrins capable of electrophilic chlorinations and proposes a mechanism for a novel catalytic approach.

Relevance of Electrophilic Chlorinations

Electrophilic chlorinations are essential chemical transformation steps as chlorinated organic compounds have an impact on many aspects of society:1,2 they are found in natural products (e.g., hapalindole A; Figure 1a),3−5 pharmaceuticals (e.g., the antibacterial drug clindamicine; Figure 1b),6−8 agrochemicals (e.g., the insecticide indoxacarb; Figure 1c),9 and organic materials.10 Furthermore, they are important reagents for cross-coupling reactions11−13 and intermediates in industrial-scale epoxidations.14 Nevertheless, in both industry and academia, methods for synthesizing these compounds via electrophilic chlorinations still rely on the use of chlorine gas or hypochlorite salts,2,14−17 which are toxic, corrosive, and nonselective. Alternatively, organic chlorinating agents, such as N-chlorosuccinimide or iodobenzene dichloride, are used.18−20 These not only require hypochlorites or chlorine gas for their synthesis21,22 but also generate stoichiometric amounts of organic waste upon usage. Hence, there has been a recent push to develop environmentally benign methods for electrophilic chlorinations.23

Figure 1.

Figure 1

Open in a new tab

Structures of (a) a chlorinated natural product isolated from the Stigonemataceae family of cyanobacteria, (b) a chlorinated antibacterial drug, and (c) a chlorinated insecticide developed by DuPont.

Halogenations in Nature

One approach to developing a new catalytic method is to draw inspiration from nature.24 Halogenating enzymes can be classified into two major types: halogenases and haloperoxidases.25−27 Halogenases use O2 as their oxidant and perform halogen transfers via a radical rebound mechanism, resulting in a one-electron-oxidized halide.25 Haloperoxidases are hydrogen peroxide (H2O2)-dependent enzymes with the ability to perform a two-electron oxidation of a halide.28 Hence, only haloperoxidases perform true electrophilic halogenations.

Within the haloperoxidases, two types of metalloenzymes are most common: vanadium-dependent bromoperoxidase and heme-dependent chloroperoxidase (CPO).25−31 Despite its natural function being the catalysis of brominations, the former has been shown to have some chlorinating ability.32 Its bioinspired halogenation has been extensively studied,33 but only a few examples of vanadium-catalyzed chlorinations have been reported34−38 as the substitution of bromide for chloride has proven to be challenging.39,40 We will thus focus on CPO-related chlorination reactions.

Chloroperoxidase (CPO)

In the 1930s, it was found that molds can metabolize chloride and incorporate it into organic products.41 In particular, the fungus Caldariomyces fumago was extensively studied and shown to produce caldariomycin in the presence of chloride.41−48 From this fungus, CPO was finally isolated and characterized in 1966,49 which enabled further analysis of its reactivity and mechanism.50−70 Structurally, CPO is a monomeric, heme-containing enzyme with a protoporphyrin IX equatorial ligand coordinating the iron (Figure 2). The active site bears polar residues on the distal side of the heme, which form a peroxide-binding site. However, unlike most peroxidases, it has a cysteine axial ligand, a feature common to cytochrome P450.66 Although it has been shown to perform a wide range of reaction types, including those typical of peroxidases, catalase, and P450s,52 its ability to catalyze electrophilic chlorinations using chloride and H2O2 at low pH values has fascinated chemists the most.50,51,53,55,56,58,60,61,63,67

Figure 2.

Figure 2

Open in a new tab

Structure of the heme complex present in the CPO active site and its model chlorination reaction with monochlorodimedone, a commonly used test substrate for CPO.30

From studies of the chlorination reactivity of isolated CPO (for an example, see Figure 2), the involvement of two main intermediates in the mechanism was inferred. H2O2 was found to react with the heme in CPO’s active site to form an iron(IV) oxo radical π-cation (Compound I),59 of which the structure was analyzed in detail by electron paramagnetic resonance (EPR),59 Mössbauer,59 resonance Raman,64 and X-ray absorption69 spectroscopies. Compound I can also be generated by using m-chloroperbenzoic acid (mCPBA).54 Upon reaction with chloride, a subsequent intermediate is suspected to be an FeIII-OCl,53,61,63,67 supported by Mössbauer spectral55 and 35Cl NMR studies,56 both of which suggest that chloride does not coordinate directly to the iron center.

Biomimetic Complexes and Their Reactivity

Active site analogues of CPO developed by the Woggon group (Figure 3) were designed in order to mimic both the first and second coordination spheres of CPO,71−74 which were elucidated in the X-ray crystal structure reported in 1995.66 By replicating CPO’s active site as closely as possible whilst omitting the bulk of the enzyme, it was envisioned that its mechanism of chlorination could be mimicked and further understood through the use of additional reaction assays and spectroscopic techniques.71−74

Figure 3.

Figure 3

Open in a new tab

Structure of the active-site analogues developed by the Woggon group (R = H, C6F5).71,73

In addition to bearing a porphyrin ligand similar to protoporphyrin IX, the biomimetic complexes feature an axial thiolate ligand to mimic the cysteine residue present in CPO. This modification is essential because the thiolate ligand has been shown to be crucial in regulating reactivity through its redox-active nature.62 Furthermore, proton donors are embedded close to the free axial position, which simulates a glutamate residue in the active site of CPO that is conveniently positioned to protonate intermediates in the reaction.66,72

With the help of these complexes, the chlorination mechanism was further investigated.71,72 The same species was generated when the iron(III) complex was reacted with either H2O2 and subsequently chloride or a hypochlorite source, further supporting the generation of an FeIII-OCl intermediate.71,72 In addition, it was found that the Fe-OCl intermediate is likely protonated prior to substrate chlorination, an aspect that is of relevance to the subsequent step involving chlorination of the substrate.71,72 Moreover, these complexes were shown to catalytically chlorinate monochlorodimedone as well as other cyclic ketones and aromatic compounds.73

In combination with the data obtained from studying CPO, the biomimetic complexes from the Woggon group enabled the mechanism to be further understood (Scheme 1).72 The resting state is thought to be an iron(III) species that is oxidized by H2O2 to Compound I. This can then react with a chloride to form the putative FeIII-OCl species, which is likely protonated before chlorination of the substrate occurs. It should be noted that while some studies suggest that substrate chlorination occurs directly from the (protonated) enzyme-bound Fe-OCl adduct,61,63,72 others have argued that, because X-ray crystallography reveals an enzyme active site lacking a substrate-binding pocket,68 HOCl must be released into the solution prior to substrate chlorination.75 In either case, a two-electron oxidation of chloride is achieved, thereby allowing the transfer of a putative “Cl+” species to a desired substrate.51

Scheme 1. Proposed Mechanism of Chloride Oxidation by CPO.

Scheme 1

Open in a new tab

The equatorial ligand, here schematically depicted as a horizontal bold line, is protoporphyrin IX.

Toward Industrial Relevance: Bioinspired Developments

Although CPO has been shown to chlorinate a wide variety of substrates, including those featuring alkene, alkyne, and aryl groups,30,76,77 the large-scale industrial application of CPO as a catalyst for electrophilic chlorinations appears challenging. Not only do most relevant substrates have low solubility in water, but CPO, like most peroxidases, suffers from peroxide-dependent inactivation.78 Efforts have been made to find ways around these challenges.78−81 However, significant developments are still required before CPO becomes industrially relevant as a catalyst for electrophilic chlorinations. The Woggon complexes have, of course, been shown to be suitable CPO mimics and are capable of performing electrophilic chlorinations catalytically, with turnover numbers ranging from 10 to 1500 in the presence of Lewis acids (for example, ZnCl2).71,73,74 Unfortunately, their syntheses are also lengthy and thus unlikely to be suitable for industrial usage.71,73 The use of a simpler ligand framework, however, may yield a fruitful method for electrophilic chlorinations.

The Fujii group employed simple meso-substituted iron porphyrin complexes in attempts to mimic the chlorination reactivity of CPO.82−84 Compound I was initially generated by the reaction of (TPFPP)Fe-NO3, where TPFPP = meso-tetra(pentafluorophenyl)porphyrin, with ozone in dichloromethane (DCM) at −90 °C. The subsequent addition of chloride to the newly formed Compound I led to a one-electron transfer from chloride to the iron complex, yielding back an iron(IV) oxo species (Compound II) and a chloride radical (Scheme 2, top).82 Hence, only a one-electron oxidation of chloride occurred rather than the expected two-electron oxidation. Complexes bearing more electron-donating meso substituents were later screened, and none were found to form the desired iron hypochlorite either.83

Scheme 2. Reactivity of Compound I with Tetrabutylammonium Chloride (TBACl) in the Absence (top) and Presence (bottom) of TFA, Studied by the Fujii Group82,84 as well as their Chlorination Reactivity of 1,3,5-Trimethoxybenzene.

Scheme 2

Open in a new tab

Reactions are performed in DCM at −90 °C. X depicts either trifluoroacetate or NO3– as the axial ligand.

Interestingly, when chloride was added to (TPFPP+·)(NO3)Fe=O in the presence of excess trifluoroacetic acid (TFA) in DCM at −90 °C, a two-electron oxidation was observed. However, rather than an iron hypochlorite being formed, the active chlorinating species in CPO, a meso-chloroisoporphyrin, was generated (Scheme 2, bottom). This species was observed by UV–vis spectroscopy and further characterized by NMR, EPR, and electrospray ionization mass spectrometry.84 Recently, the crystal structure of a similar meso-chloroisoporphyrin was published by the McDonald group.85 Upon reaction with cyclohexene, 1,3,5-trimethoxybenzene, and anisole, the isoporphyrin was shown to be capable of electrophilic chlorinations (Scheme 2), yielding back an iron(III) porphyrin complex in the process.84 Thus, although these simple complexes show reactivity that largely deviates from that of CPO and the biomimetic complexes from the Woggon group, they can form transient species that bear promise as electrophilic chlorinating agents.

It should be noted that (TPFPP)Fe-OCl can be generated from (TPFPP)Fe-OH by ligand exchange with tetrabutylammonium hypochlorite (TBAOCl) in DCM/acetonitrile (1:1) at −60 °C.86 At room temperature though, this species rapidly decomposes to Compound II. At first glance, this would indicate that the FeO–Cl bond has a tendency to cleave homolytically, generating only a one-electron-oxidized chlorine species. However, upon further inspection and screening of complexes with more electron-donating meso substituents, it appeared that the FeO–Cl bond breaks heterolytically to form Compound I. In the presence of excess TBAOCl, complexes for which Compound I has a reduction potential larger than that of the hypochlorite anion are reduced from Compound I to Compound II by an electron-transfer process. This is true for complexes bearing strongly electron-withdrawing meso substituents, such as 2,6-dichlorophenyl and 2,4,6-trichlorophenyl (Scheme 3).83 The fact that heterolytic cleavage of the O–Cl bond occurs, forming Compound I and chloride, indicates that, by microscopic reversibility, biomimetic formation of an Fe-OCl should be possible. It might just not be energetically accessible.

Scheme 3. Mechanism of (porphyrin)Fe-OCl Formation and Decomposition,83.

Scheme 3

Open in a new tab

EW = electron withdrawing. The equatorial ligand, here schematically depicted as a horizontal bold line, is a meso-substituted porphyrin.

Similar to meso-chloroisoporphyrin, (TPFPP)Fe-OCl is capable of chlorinating 1,3,5-trimethoxybenzene (Scheme 2). However, it epoxidizes cyclohexene rather than chlorinating it, as shown for the isoporphyrin.86 Hence, the isoporphyrin not only is more accessible than the iron porphyrin hypochlorite but appears to be a superior chlorinating agent. The challenge remains to transform the stoichiometric chlorination, which employs a preformed meso-chloroisoporphyrin, into a functioning catalytic pathway. For this, a further understanding of the possible mechanism is required.

The generation of Compound I for meso-substituted iron porphyrin complexes is relatively well understood.87−91 On the contrary, the conversion of Compound I to an isoporphyrin under acidic conditions remains largely understudied. However, a recent study by the Karlin group does elucidate one of the intermediates. When (TDFPP)Fe(SbF6), where TDFPP = 5,10,15,20-tetrakis(2,6-difluorophenyl)porphyrin, was oxidized to Compound I and subsequently reacted with TFA, a transient iron(III) π-dication species was formed. This was then shown to react with nucleophiles (including chloride) to generate an isoporphyrin (Scheme 4).92 Hence, we expect the formation of a meso-chloroisoporphyrin to proceed through an iron(III) complex bearing a doubly oxidized porphyrin ligand.

Scheme 4. Identification of the π-Dication Intermediate in the Pathway toward an Isoporphyrin,92.

Scheme 4

Open in a new tab

Ar = 2,6-difluorophenyl. Nuc = a nucleophile (e.g., 4,5-dimethylimidazole or chloride). X represents any anionic coordinating ligand present in solution.

These iron(III) π-dication species, first characterized in 1993 by UV–vis, 1H NMR, and EPR,93 are rather uncommon, and only a few examples of π-dication metalloporphyrin complexes have been reported in general.94−96 Interestingly, however, it was already proposed in 1970 that isoporphyrins could be synthesized by an electrochemical 2-fold oxidation of a zinc(II) species in the presence of a nucleophile.97

Potential Bioinspired Catalytic Approach

From the aforementioned data available in the literature, we can infer a potential catalytic cycle for bioinspired iron-catalyzed electrophilic chlorinations employing simple iron porphyrin complexes (Scheme 5). An iron(III) species is first oxidized to Compound I. Commonly, this is done through the use of mCPBA or ozone.90 However, the use of the more environmentally benign oxidant H2O2 is possible under certain conditions.87,88 As was elucidated by the Karlin group, Compound I converts to a π-dication by reaction with acid.92 Chloride can then attack the porphyrin ring, forming a meso-chloroisoporphyrin, which is capable of electrophilic chlorinations. Upon chlorination from an isoporphyrin, an iron(III) species is recovered,84 allowing the catalytic cycle to be closed. Although each of the transformations has been performed sequentially, no attempts at catalysis have been reported. Thus, we emphasize that the proposed catalytic cycle is for now purely hypothetical and has yet to be shown experimentally viable. We are hopeful though that, with further research, it could lead to a novel method for environmentally benign electrophilic chlorinations.

Scheme 5. Possible Catalytic Cycle for Bioinspired Iron-Catalyzed Electrophilic Chlorinations Employing Simple Iron Porphyrin Species.

Scheme 5

Open in a new tab

[Ox] refers to any oxidant capable of oxidizing to Compound I. X represents any anionic coordinating ligand in solution. The equatorial ligand, here schematically depicted as a horizontal bold line, is a meso-substituted porphyrin.

Conclusion

Although the proposed direction outlined here has deviated largely from the mechanism of CPO, we believe that the hypothetical bioinspired approach, composed from several experimental observations, holds promise. In contrast to the biomimetic route, the proposed alternative does not form (toxic and corrosive) hypochlorites at any point in the cycle, possibly making it even more environmentally benign. Moreover, the meso-chloroisoporphyrins could be more specific because they are unlikely to yield epoxidation products instead of the desired chlorinations, which has been reported to occur for iron hypochlorite species.86 Furthermore, we hope to have demonstrated how drawing inspiration from nature can be a powerful tool and open up novel avenues in the pursuit of exploring chemical reactivity.

Acknowledgments

J.E.M.N.K. acknowledges funding from The Netherlands Organisation for Scientific Research (NWO ENW-Klein grant).

The authors declare no competing financial interest.

References

  1. Fauvarque J. The chlorine industry. Pure Appl. Chem. 1996, 68, 1713–1720. 10.1351/pac199668091713. [DOI] [Google Scholar]
  2. Treger Y.; Flid M.. State of the Art and Problems of Organochlorine Synthesis. In Chemistry Beyond Chlorine; Tundo P., He L.-N., Lokteva E., Mota C., Eds.; Springer International Publishing: Cham, Switzerland, 2016; pp 533–555. [Google Scholar]
  3. Gribble G. W. Naturally Occurring Organohalogen Compounds. Acc. Chem. Res. 1998, 31, 141–152. 10.1021/ar9701777. [DOI] [Google Scholar]
  4. La Regina G.; D’Auria F. D.; Tafi A.; Piscitelli F.; Olla S.; Caporuscio F.; Nencioni L.; Cirilli R.; La Torre F.; De Melo N. R.; Kelly S. L.; Lamb D. C.; Artico M.; Botta M.; Palamara A. T.; Silvestri R. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, New Imidazoles with Potent Activity against Candida albicans and Dermatophytes. Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies. J. Med. Chem. 2008, 51, 3841–3855. 10.1021/jm800009r. [DOI] [PubMed] [Google Scholar]
  5. Richter J. M.; Ishihara Y.; Masuda T.; Whitefield B. W.; Llamas T.; Pohjakallio A.; Baran P. S. Enantiospecific Total Synthesis of the Hapalindoles, Fischerindoles, and Welwitindolinones via a Redox Economic Approach. J. Am. Chem. Soc. 2008, 130, 17938–17954. 10.1021/ja806981k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fang W. Y.; Ravindar L.; Rakesh K. P.; Manukumar H. M.; Shantharam C. S.; Alharbi N. S.; Qin H. L. Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review. Eur. J. Med. Chem. 2019, 173, 117–153. 10.1016/j.ejmech.2019.03.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jain A.; Duvvuri L. S.; Farah S.; Beyth N.; Domb A. J.; Khan W. Antimicrobial Polymers. Adv. Healthcare Mater. 2014, 3, 1969–1985. 10.1002/adhm.201400418. [DOI] [PubMed] [Google Scholar]
  8. Birkenmeyer R. D.; Kroll S. J.; Lewis C.; Stern K. F.; Zurenko G. E. Synthesis and Antimicrobial Activity of Clindamycin Analogues: Pirlimycin, a Potent Antibacterial Agent. J. Med. Chem. 1984, 27, 216–223. 10.1021/jm00368a020. [DOI] [PubMed] [Google Scholar]
  9. Xu D.; Guan J.; Xu X.; Gong S.; Xu H. A New Method for the Synthesis of Oxadiazine Insecticide Indoxacarb. J. Heterocyclic Chem. 2016, 53, 1469–1473. 10.1002/jhet.2449. [DOI] [Google Scholar]
  10. Tang M. L.; Bao Z. Halogenated Materials as Organic Semiconductors. Chem. Mater. 2011, 23, 446–455. 10.1021/cm102182x. [DOI] [Google Scholar]
  11. Devendar P.; Qu R. Y.; Kang W. M.; He B.; Yang G. F. Palladium-Catalyzed Cross-Coupling Reactions: A Powerful Tool for the Synthesis of Agrochemicals. J. Agric. Food Chem. 2018, 66, 8914–8934. 10.1021/acs.jafc.8b03792. [DOI] [PubMed] [Google Scholar]
  12. González-Sebastián L.; Morales-Morales D. Cross-coupling reactions catalysed by palladium pincer complexes. A review of recent advances. J. Organomet. Chem. 2019, 893, 39–51. 10.1016/j.jorganchem.2019.04.021. [DOI] [Google Scholar]
  13. Lundgren R. J.; Stradiotto M. Addressing challenges in palladium-catalyzed cross-coupling reactions through ligand design. Chem. Eur. J. 2012, 18, 9758–9769. 10.1002/chem.201201195. [DOI] [PubMed] [Google Scholar]
  14. Kobe J. M.; Evans W. E.; June R. L.; Lemanski M. F., Epoxidations—Industrial. In Encyclopedia of Catalysis; Horváth I. T., Ed.; John Wiley & Sons, Inc., 2002. [Google Scholar]
  15. Schrimpf R. M.; Tietje R. K.; Toupence R. B.; Ji J.; Basha A.; Bunnelle W. H.; Daanen J. F.; Pace J. M.; Sippy K. B.. Diazabicyclic central nervous system active agents. Patent application WO2001081347, 2001.
  16. Lyhs B.; Blaser D.; Wolper C.; Schulz S.; Jansen G. A comparison of the solid-state structures of halogen azides XN3 (X = Cl, Br, I). Angew. Chem., Int. Ed. 2012, 51, 12859–12863. 10.1002/anie.201206028. [DOI] [PubMed] [Google Scholar]
  17. Köhn R. D.; Coxon A. G. N.; Hawkins C. R.; Smith D.; Mihan S.; Schuhen K.; Schiendorfer M.; Kociok-Köhn G. Selective trimerisation and polymerisation of ethylene: Halogenated chromium triazacyclohexane complexes as probes for an internal ‘halogen effect’. Polyhedron 2014, 84, 3–13. 10.1016/j.poly.2014.05.050. [DOI] [Google Scholar]
  18. Maddox S. M.; Nalbandian C. J.; Smith D. E.; Gustafson J. L. A practical Lewis base catalyzed electrophilic chlorination of arenes and heterocycles. Org. Lett. 2015, 17, 1042–1045. 10.1021/acs.orglett.5b00186. [DOI] [PubMed] [Google Scholar]
  19. Hering T.; König B. Photocatalytic activation of N-chloro compounds for the chlorination of arenes. Tetrahedron 2016, 72, 7821–7825. 10.1016/j.tet.2016.06.028. [DOI] [Google Scholar]
  20. Xiong X.; Yeung Y. Y. Highly ortho-Selective Chlorination of Anilines Using a Secondary Ammonium Salt Organocatalyst. Angew. Chem., Int. Ed. 2016, 55, 16101–16105. 10.1002/anie.201607388. [DOI] [PubMed] [Google Scholar]
  21. Blacker A. J.; Jolley K. E. Continuous formation of N-chloro-N,N-dialkylamine solutions in well-mixed meso-scale flow reactors. Beilstein J. Org. Chem. 2015, 11, 2408–2417. 10.3762/bjoc.11.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Xu J.; Yang Z. Convenient and Environment-Friendly Synthesis of Sulfonyl Chlorides from S-Alkylisothiourea Salts via N-Chlorosuccinimide Chlorosulfonation. Synthesis 2013, 45, 1675–1682. 10.1055/s-0033-1338743. [DOI] [Google Scholar]
  23. Podgorsek A.; Zupan M.; Iskra J. Oxidative halogenation with ″green″ oxidants: oxygen and hydrogen peroxide. Angew. Chem., Int. Ed. 2009, 48, 8424–8450. 10.1002/anie.200901223. [DOI] [PubMed] [Google Scholar]
  24. Réglier M.Bioinspired Chemistry from Enzymes to Synthetic Models; World Scientific: Singapore, 2019. [Google Scholar]
  25. Ludewig H.; Molyneux S.; Ferrinho S.; Guo K.; Lynch R.; Gkotsi D. S.; Goss R. J. Halogenases: structures and functions. Curr. Opin. Struct. Biol. 2020, 65, 51–60. 10.1016/j.sbi.2020.05.012. [DOI] [PubMed] [Google Scholar]
  26. Vaillancourt F. H.; Yeh E.; Vosburg D. A.; Garneau-Tsodikova S.; Walsh C. T. Nature’s Inventory of Halogenation Catalysts: Oxidative Strategies Predominate. Chem. Rev. 2006, 106, 3364–3378. 10.1021/cr050313i. [DOI] [PubMed] [Google Scholar]
  27. Crowe C.; Molyneux S.; Sharma S. V.; Zhang Y.; Gkotsi D. S.; Connaris H.; Goss R. J. M. Halogenases: a palette of emerging opportunities for synthetic biology-synthetic chemistry and C-H functionalisation. Chem. Soc. Rev. 2021, 50, 9443–9481. 10.1039/D0CS01551B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hofler G. T.; But A.; Hollmann F. Haloperoxidases as catalysts in organic synthesis. Org. Biomol. Chem. 2019, 17, 9267–9274. 10.1039/C9OB01884K. [DOI] [PubMed] [Google Scholar]
  29. Leblanc C.; Vilter H.; Fournier J. B.; Delage L.; Potin P.; Rebuffet E.; Michel G.; Solari P. L.; Feiters M. C.; Czjzek M. Vanadium haloperoxidases: From the discovery 30 years ago to X-ray crystallographic and V K-edge absorption spectroscopic studies. Coord. Chem. Rev. 2015, 301–302, 134–146. 10.1016/j.ccr.2015.02.013. [DOI] [Google Scholar]
  30. Hofrichter M.; Ullrich R. Heme-thiolate haloperoxidases: versatile biocatalysts with biotechnological and environmental significance. Appl. Microbiol. Biotechnol. 2006, 71, 276–288. 10.1007/s00253-006-0417-3. [DOI] [PubMed] [Google Scholar]
  31. Winter J. M.; Moore B. S. Exploring the chemistry and biology of vanadium-dependent haloperoxidases. J. Biol. Chem. 2009, 284, 18577–81. 10.1074/jbc.R109.001602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Soedjak H. S.; Butler A. Chlorination Catalyzed by Vanadium Bromoperoxidase. Inorg. Chem. 1990, 29, 5015–5017. 10.1021/ic00350a003. [DOI] [Google Scholar]
  33. Langeslay R. R.; Kaphan D. M.; Marshall C. L.; Stair P. C.; Sattelberger A. P.; Delferro M. Catalytic Applications of Vanadium: A Mechanistic Perspective. Chem. Rev. 2019, 119, 2128–2191. 10.1021/acs.chemrev.8b00245. [DOI] [PubMed] [Google Scholar]
  34. Dinesh C. U.; Kumar R.; Pandey B.; Kumar P. Catalytic Halogenation of Selected Organic Compounds Mimicking Vanadate-dependent Marine Metalloenzymes. J. Chem. Soc., Chem. Commun. 1995, 611–612. 10.1039/c39950000611. [DOI] [Google Scholar]
  35. Mba M.; Pontini M.; Lovat S.; Zonta C.; Bernardinelli G.; Kündig P. E.; Licini G. C3 Vanadium(V) Amine Triphenolate Complexes: Vanadium Haloperoxidase Structural and Functional Models. Inorg. Chem. 2008, 47, 8616–8618. 10.1021/ic8015113. [DOI] [PubMed] [Google Scholar]
  36. Rana S.; Haque R.; Santosh G.; Maiti D. Decarbonylative halogenation by a vanadium complex. Inorg. Chem. 2013, 52, 2927–2932. 10.1021/ic302611a. [DOI] [PubMed] [Google Scholar]
  37. Moriuchi T.; Fukui Y.; Kato S.; Kajikawa T.; Hirao T. Vanadium-catalyzed chlorination under molecular oxygen. J. Inorg. Biochem. 2015, 147, 177–180. 10.1016/j.jinorgbio.2015.01.015. [DOI] [PubMed] [Google Scholar]
  38. Rana S.; Pandey B.; Dey A.; Haque R.; Rajaraman G.; Maiti D. A Doubly Biomimetic Synthetic Transformation: Catalytic Decarbonylation and Halogenation at Room Temperature by Vanadium Pentoxide. ChemCatChem. 2016, 8, 3367–3374. 10.1002/cctc.201600843. [DOI] [Google Scholar]
  39. Kikushima K.; Moriuchi T.; Hirao T. Oxidative bromination reaction using vanadium catalyst and aluminum halide under molecular oxygen. Tetrahedron Lett. 2010, 51, 340–342. 10.1016/j.tetlet.2009.11.016. [DOI] [Google Scholar]
  40. Galloni P.; Mancini M.; Floris B.; Conte V. A sustainable two-phase procedure for V-catalyzed toluene oxidative bromination with H2O2-KBr. Dalton Trans. 2013, 42, 11963–11970. 10.1039/c3dt50907a. [DOI] [PubMed] [Google Scholar]
  41. Clutterbuck P. W.; Mukhopadhyay S. L.; Oxford A. E.; Raistrick H. Studies in the Biochemistry of Micro-organisms. Biochem. J. 1940, 34, 664–677. 10.1042/bj0340664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shaw P. D.; Hager L. P. An Enzymatic Chlorination Reaction. J. Am. Chem. Soc. 1959, 81, 1011–1012. 10.1021/ja01513a069. [DOI] [Google Scholar]
  43. Shaw P. D.; Beckwith J. R.; Hager L. P. Biological Chlorination. II. The Biosynthesis of δ-Chlorolevulinic Acid. J. Biol. Chem. 1959, 234, 2560–2564. 10.1016/S0021-9258(18)69738-8. [DOI] [PubMed] [Google Scholar]
  44. Shaw P. D.; Hager L. P. Biological Chlorination. III. β-ketoadipate Chlorinase: A soluble Enzyme System. J. Biol. Chem. 1959, 234, 2565–2569. 10.1016/S0021-9258(18)69739-X. [DOI] [PubMed] [Google Scholar]
  45. Shaw P. D.; Hager L. P. Biological Chlorination. IV. Peroxidative Nature of Enzymatic Chlorination. J. Am. Chem. Soc. 1959, 81, 6527–6528. 10.1021/ja01533a056. [DOI] [Google Scholar]
  46. Shaw P. D.; Hager L. P. Biological Chlorination. VI. Chloroperoxidase: A Component of the β-ketoadipate Chlroinase System. J. Biol. Chem. 1961, 236, 1626–1630. 10.1016/S0021-9258(19)63275-8. [DOI] [Google Scholar]
  47. Beckwith J. R.; Clark R.; Hager L. P. Biological Chlorination. VII. Studies on the Biosynthesis of Caldariomycin. J. Biol. Chem. 1963, 238, 3086–3090. 10.1016/S0021-9258(18)51870-6. [DOI] [PubMed] [Google Scholar]
  48. Beckwith J. R.; Hager L. P. Biological Chlorination. VIII. Late Intermediates in the Biosynthesis of Caldariomycin. J. Biol. Chem. 1963, 238, 3091–3094. 10.1016/S0021-9258(18)51871-8. [DOI] [PubMed] [Google Scholar]
  49. Morris D. R.; Hager L. P. Chloroperoxidase. I. Isolation and Properties of the Crystalline Glycoprotein. J. Biol. Chem. 1966, 241, 1763–1768. 10.1016/S0021-9258(18)96701-3. [DOI] [PubMed] [Google Scholar]
  50. Hager L. P.; Morris D. R.; Brown F. S.; Eberwein H. Chloroperoxidase. II. Utilization of Halogen Anions. J. Biol. Chem. 1966, 241, 1769–1777. 10.1016/S0021-9258(18)96702-5. [DOI] [PubMed] [Google Scholar]
  51. Brown F. S.; Hager L. P. Chloroperoxidase. IV. Evidence of an Ionic Electrophilic Substituion Mechanism. J. Am. Chem. Soc. 1967, 89, 719–720. 10.1021/ja00979a061. [DOI] [PubMed] [Google Scholar]
  52. Thomas J. A.; Morris D. R.; Hager L. P. Chloroperoxidase. VII. Classical Peroxidatic, Catalytic, and Halogenating Forms of the Enzyme. J. Biol. Chem. 1970, 245, 3129–3134. 10.1016/S0021-9258(18)63032-7. [DOI] [PubMed] [Google Scholar]
  53. Thomas J. A.; Morris D. R.; Hager L. P. Chloroperoxidase. VIII. Formation of Peroxide and Halide Complexes and their Relation to the Mechanism of the Halogenation Reaction. J. Biol. Chem. 1970, 245, 3135–3142. 10.1016/S0021-9258(18)63033-9. [DOI] [PubMed] [Google Scholar]
  54. Hager L. P.; Doubek D. L.; Silverstein R. M.; Hargis J. H.; Martin J. C. Chloroperoxidase. IX. The Structure of Compound I. J. Am. Chem. Soc. 1972, 94, 4364–4366. 10.1021/ja00767a068. [DOI] [PubMed] [Google Scholar]
  55. Champion P. M.; Münck E.; Debrunner P. G.; Hollenberg P. F.; Hager L. P. Mössbauer Investigations of Chloroperoxidase and Its Halide Complexes. Biochem. 1973, 12, 426–435. 10.1021/bi00727a011. [DOI] [PubMed] [Google Scholar]
  56. Krejcarek G. E.; Bryant R. G.; Smith R. J.; Hager L. P. Broad-Line Nuclear Magnetic Resonance Studies of Chloroperoxidase. Biochem. 1976, 15, 2508–2511. 10.1021/bi00657a002. [DOI] [PubMed] [Google Scholar]
  57. Remba R. D.; Champion P. M.; Fitchen D. B.; Chiang R.; Hager L. P. Resonance Raman Investigations of Chloroperoxidase, Horseradish Peroxidase, and Cytochrome c Using Soret Band Laser Excitation. Biochem. 1979, 18, 2280–2290. 10.1021/bi00578a023. [DOI] [PubMed] [Google Scholar]
  58. Hollenberg P. F.; Hager L. P.; Blumberg W. E.; Peisach J. An electron paramagnetic resonance study of the high and low spin forms of chloroperoxidase. J. Biol. Chem. 1980, 255, 4801–4807. 10.1016/S0021-9258(19)85568-0. [DOI] [PubMed] [Google Scholar]
  59. Rutter R.; Hager L. P.; Dhonau H.; Hendrich M.; Valentine M.; Debrunner P. Chloroperoxidase Compound I: Electron Paramagnetic Resonance and Mössbauer Studies. Biochem. 1984, 23, 6809–6816. 10.1021/bi00321a082. [DOI] [PubMed] [Google Scholar]
  60. Sono M.; Dawson J. H.; Hager L. P. Ligand and Halide Binding Properties of Chloroperoxidase: Peroxidase-Type Active Site Heme Environment with Cytochrome P-450 Type Endogenous Axial Ligand and Spectroscopic Properties. Biochem. 1986, 25, 347–356. 10.1021/bi00350a011. [DOI] [PubMed] [Google Scholar]
  61. Dunford H. B.; Lambeir A.-M.; Kashem M. A.; Pickard M. On the Mechanism of Chlorination by Chloroperoxidase. Arch. Biochem. Biophys. 1987, 252, 292–302. 10.1016/0003-9861(87)90034-8. [DOI] [PubMed] [Google Scholar]
  62. Dawson J. H.; Sono M. Cytochrome P-450 and Chloroperoxidase: Thiolate-Ligated Heme Enzymes. Spectroscopic Determination of Their Active Site Structures and Mechanistic Implications of Thiolate Ligation. Chem. Rev. 1987, 87, 1255–1276. 10.1021/cr00081a015. [DOI] [Google Scholar]
  63. Libby R. D.; Shedd A. L.; Phipps A. K.; Beachy T. M.; Gerstberger S. M. Defining the involvement of HOCl or Cl2 as enzyme-generated intermediates in chloroperoxidase-catalyzed reactions. J. Biol. Chem. 1992, 267, 1769–1775. 10.1016/S0021-9258(18)46012-7. [DOI] [PubMed] [Google Scholar]
  64. Hosten C. M.; Sullivan A. M.; Palaniappan V.; Fitzgerald M. M.; Terner J. Resonance Raman spectroscopy of the catalytic intermediates and derivatives of chloroperoxidase from Caldariomyces fumago. J. Biol. Chem. 1994, 269, 13966–13978. 10.1016/S0021-9258(17)36742-X. [DOI] [PubMed] [Google Scholar]
  65. Liu H. I.; Sono M.; Kadkhodayan S.; Hager L. P.; Hedman B.; Hodgson K. O.; Dawson J. H. X-ray absorption near edge studies of cytochrome P-450-CAM, chloroperoxidase, and myoglobin. Direct evidence for the electron releasing character of a cysteine thiolate proximal ligand. J. Biol. Chem. 1995, 270, 10544–50. 10.1074/jbc.270.18.10544. [DOI] [PubMed] [Google Scholar]
  66. Sundaramoorthy M.; Terner J.; Poulos T. L. The crystal structure of chloroperoxidase: a heme peroxidase-cytochrome P450 functional hybrid. Structure 1995, 3, 1367–1377. 10.1016/S0969-2126(01)00274-X. [DOI] [PubMed] [Google Scholar]
  67. Libby R. D.; Beachy T. M.; Phipps A. K. Quantitating direct chlorine transfer from enzyme to substrate in chloroperoxidase-catalyzed reactions. J. Biol. Chem. 1996, 271, 21820–21827. 10.1074/jbc.271.36.21820. [DOI] [PubMed] [Google Scholar]
  68. Sundaramoorthy M.; Terner J.; Poulos T. L. Stereochemistry of the chloroperoxidase active site: crystallographic and molecular-modeling studies. Chem. Biol. 1998, 5, 461–473. 10.1016/S1074-5521(98)90003-5. [DOI] [PubMed] [Google Scholar]
  69. Stone K. L.; Behan R. K.; Green M. T. X-ray absorption spectroscopy of chloroperoxidase compound I: Insight into the reactive intermediate of P450 chemistry. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 16563–16565. 10.1073/pnas.0507069102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Kühnel K.; Derat E.; Terner J.; Shaik S.; Schlichting I. Structure and quantum chemical characterization of chloroperoxidase compound 0, a common reaction intermediate of diverse heme enzymes. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 99–104. 10.1073/pnas.0606285103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Wagenknecht H.-A.; Woggon W.-D. New Active-Site Analogues of Chloroperoxidase - Syntheses and Catalytic Reactions. Angew. Chem., Int. Ed. 1997, 36, 390–392. 10.1002/anie.199703901. [DOI] [Google Scholar]
  72. Wagenknecht H.-A.; Woggon W.-D. Identification of intermediates in the catalytic cycle of chloroperoxidase. Chem. Biol. 1997, 4, 367–372. 10.1016/S1074-5521(97)90127-7. [DOI] [PubMed] [Google Scholar]
  73. Wagenknecht H.-A.; Claude C.; Woggon W.-D. New Enzyme Models of Chloroperoxidase: Improved Stability and Catalytic Efficiency of Iron Porphyrinates Containing a Thiolato Ligand. Helv. Chim. Acta 1998, 81, 1506–1520. 10.1002/hlca.19980810554. [DOI] [Google Scholar]
  74. Woggon W.-D.; Wagenknecht H.-A.; Claude C. Synthetic active site analogues of heme–thiolate proteins. Characterization and identification of intermediates of the catalytic cycles of cytochrome P450cam and chloroperoxidase. J. Inorg. Biochem. 2001, 83, 289–300. 10.1016/S0162-0134(00)00175-6. [DOI] [PubMed] [Google Scholar]
  75. Timmins A.; Visser S. P. d.. Enzymatic Halogenases and Haloperoxidases: Computational Studies on Mechanism and Function. In Advances in Protein Chemistry and Structural Biology; Karabencheva-Christova T., Ed.; Academic Press, 2015; Vol. 100, Chapter 5, pp 113–151. [DOI] [PubMed] [Google Scholar]
  76. Walter B.; Ballschmiter K. Formation of C1/C2-bromo-/chloro-hydrocarbons by haloperoxidase reactions. Fresenius J. Anal. Chem. 1992, 342, 827–833. 10.1007/BF00322143. [DOI] [Google Scholar]
  77. Liu K. K.-C.; Wong C.-H. Enzymatic Halohydration of Glycals. J. Org. Chem. 1992, 57, 3748–3750. 10.1021/jo00039a050. [DOI] [Google Scholar]
  78. Andersson M.; Andersson M. M.; Adlercreutz P. Stabilisation of Chloroperoxidase Towards Peroxide Dependent Inactivation. Biocatal. Biotransform. 2000, 18, 457–469. 10.3109/10242420009015263. [DOI] [Google Scholar]
  79. Seelbach K.; van Deurzen M. P. J.; van Rantwijk F.; Sheldon R. A.; Kragl U. Improvement of the Total Turnover Number and Space-Time Yield for Chloroperoxidase Catalyzed Oxidation. Biotechnol. Bioeng. 1997, 55, 283–288. . [DOI] [PubMed] [Google Scholar]
  80. Spreti N.; Germani R.; Incani A.; Savelli G. Stabilization of Chloroperoxidase by Polyethylene Glycols in Aqueous Media: Kinetic Studies and Synthetic Applications. Biotechnol. Prog. 2004, 20, 96–101. 10.1021/bp034167i. [DOI] [PubMed] [Google Scholar]
  81. van de Velde F.; Bakker M.; van Rantwijk F.; Sheldon R. A. Chloroperoxidase-Catalyzed Enantioselective Oxidations in Hydrophobic Organic Media. Biotechnol. Bioeng. 2001, 72, 523–529. . [DOI] [PubMed] [Google Scholar]
  82. Cong Z.; Kurahashi T.; Fujii H. Oxidation of chloride and subsequent chlorination of organic compounds by oxoiron(IV) porphyrin π-cation radicals. Angew. Chem., Int. Ed. 2011, 50, 9935–9939. 10.1002/anie.201104461. [DOI] [PubMed] [Google Scholar]
  83. Yokota S.; Fujii H. Critical Factors in Determining the Heterolytic versus Homolytic Bond Cleavage of Terminal Oxidants by Iron(III) Porphyrin Complexes. J. Am. Chem. Soc. 2018, 140, 5127–5137. 10.1021/jacs.7b13037. [DOI] [PubMed] [Google Scholar]
  84. Cong Z.; Kurahashi T.; Fujii H. Formation of iron(III) meso-chloro-isoporphyrin as a reactive chlorinating agent from oxoiron(IV) porphyrin π-cation radical. J. Am. Chem. Soc. 2012, 134, 4469–4472. 10.1021/ja209985v. [DOI] [PubMed] [Google Scholar]
  85. Gericke R.; Doyle L. M.; Farquhar E. R.; McDonald A. R. Oxo-Free Hydrocarbon Oxidation by an Iron(III)-Isoporphyrin Complex. Inorg. Chem. 2020, 59, 13952–13961. 10.1021/acs.inorgchem.0c01618. [DOI] [PubMed] [Google Scholar]
  86. Cong Z.; Yanagisawa S.; Kurahashi T.; Ogura T.; Nakashima S.; Fujii H. Synthesis, Characterization, and Reactivity of Hypochloritoiron(III) Porphyrin Complexes. J. Am. Chem. Soc. 2012, 134, 20617–20620. 10.1021/ja3108774. [DOI] [PubMed] [Google Scholar]
  87. Cunningham I. D.; Basaleh A.; Gazzaz H. A. Pre-steady state reactivity of 5,10,15,20-tetrakis(pentafluorophenyl)-21H,23H-porphyrin iron(III) chloride with hydrogen peroxide. Dalton Trans. 2012, 41, 9158–9160. 10.1039/c2dt31107k. [DOI] [PubMed] [Google Scholar]
  88. Franke A.; Fertinger C.; van Eldik R. Axial ligand and spin-state influence on the formation and reactivity of hydroperoxo-iron(III) porphyrin complexes. Chem. Eur. J. 2012, 18, 6935–6949. 10.1002/chem.201103036. [DOI] [PubMed] [Google Scholar]
  89. Bhunia S.; Rana A.; Dey S. G.; Ivancich A.; Dey A. A designed second-sphere hydrogen-bond interaction that critically influences the O-O bond activation for heterolytic cleavage in ferric iron-porphyrin complexes. Chem. Sci. 2020, 11, 2681–2695. 10.1039/C9SC04388H. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Ishimizu Y.; Ma Z.; Hada M.; Fujii H. Experimental and theoretical studies of the porphyrin ligand effect on the electronic structure and reactivity of oxoiron(iv) porphyrin π-cation-radical complexes. J. Biol. Inorg. Chem. 2019, 24, 483–494. 10.1007/s00775-019-01664-3. [DOI] [PubMed] [Google Scholar]
  91. Pan Z.; Newcomb M. Acid-catalyzed disproportionation of oxoiron(IV) porphyrins to give oxoiron(IV) porphyrin radical cations. Inorg. Chem. Commun. 2011, 14, 968–970. 10.1016/j.inoche.2011.03.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Ehudin M. A.; Senft L.; Franke A.; Ivanovic-Burmazovic I.; Karlin K. D. Formation and Reactivity of New Isoporphyrins: Implications for Understanding the Tyr-His Cross-Link Cofactor Biogenesis in Cytochrome c Oxidase. J. Am. Chem. Soc. 2019, 141, 10632–10643. 10.1021/jacs.9b01791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Tsurumaki H.; Watanabe Y.; Morishima I. Preparation, Characterization, and Reactions of Novel Iron(III) Porphyrin Dication Complexes. J. Am. Chem. Soc. 1993, 115, 11784–11788. 10.1021/ja00078a017. [DOI] [Google Scholar]
  94. Fajer J.; Borg D. C.; Forman A.; Dolphin D.; Felton R. H. π-Cation Radicals and Dications of Metalloporphyrins. J. Am. Chem. Soc. 1970, 92, 3451–3459. 10.1021/ja00714a038. [DOI] [PubMed] [Google Scholar]
  95. Harriman A.; Porter G.; Walters P. Photo-oxidation of Metalloporphyrins in Aqueous Solution. J. Chem. Soc., Faraday Trans. 1983, 79, 1335–1350. 10.1039/f19837901335. [DOI] [Google Scholar]
  96. Pandit Y. A.; Shah S. J.; Rath S. P. Unusual Stabilization of Dication Diradical Intermediate of Dizinc(II) Porphyrin Dimer. Z. Anorg. Allg. Chem. 2018, 644, 856–863. 10.1002/zaac.201800247. [DOI] [Google Scholar]
  97. Dolphin D.; Felton R. H.; Borg D. C.; Fajer J. Isoporphyrins. J. Am. Chem. Soc. 1970, 92, 743–745. 10.1021/ja00706a076. [DOI] [PubMed] [Google Scholar]

Articles from Inorganic Chemistry are provided here courtesy of American Chemical Society

RESOURCES